MCA
RMD icon

McGuire Capital Advisors’s ResMed RMD Stock Holding History

McGuire Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51K Sell
18
-75
-81% -$15.5K ﹤0.01% 622
2026
Q1 		$20.9K Sell
93
-404
-81% -$101K 0.01% 282
2025
Q4 		$120K Buy
+497
New +$127K 0.08% 127

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

McGuire Capital Advisors's RMD Position: Q2 2026 in Review

McGuire Capital Advisors reduced its ResMed (RMD) stake by 81% in Q2 2026, selling an estimated $15.5K and leaving 18 shares worth $3.51K. The position accounts for ﹤0.01% of the portfolio, ranked #622.

McGuire Capital Advisors first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $120K in Q4 2025. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • McGuire Capital Advisors held 18 shares of ResMed worth $3.51K as of Q2 2026.
  • McGuire Capital Advisors sold 75 ResMed shares in Q2 2026, an estimated $15.5K.
  • ResMed made up ﹤0.01% of McGuire Capital Advisors's portfolio in Q2 2026, its #622 holding.
  • McGuire Capital Advisors first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • McGuire Capital Advisors's ResMed position peaked at $120K in Q4 2025.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.